Log In Sign up
The largest database of trusted experimental protocols

Encepur

Manufactured by GlaxoSmithKline
Visit Supplier

Encepur is a laboratory equipment product developed by GlaxoSmithKline. It is designed for the analysis and detection of various biological samples and compounds. The core function of Encepur is to provide accurate and reliable results to support scientific research and clinical applications.

Automatically generated - may contain errors

Lab products found in correlation

Stamaril, by Sanofi (1 mentions)

2 protocols using encepur

1

Titers of TBE Vaccine Recipient Sera

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 36 anonymous serum samples from TBE vaccine recipients was included in our study from the German National Consultant Laboratory for TBEV. Sera from TBE vaccinated individuals (FSME-IMMUN®, Pfizer (no. 11); Encepur®, GSK (no. 12); or a combination of FSME-IMMUN® and Encepur® (no. 13)) who, according to anamnestic information, had never suffered from TBE. All individuals had a complete basic immunization, and the last vaccine shot was more than 3 months before blood sampling. Sera were stored at − 80 °C until use.
Lindqvist R., Rosendal E., Weber E., Asghar N., Schreier S., Lenman A., Johansson M., Dobler G., Bestehorn M., Kröger A, & Överby A.K. (2020). The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection. Journal of Neuroinflammation, 17, 284.
+ Open protocol
+ Expand
2

Intramuscular Vaccination Immune Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy adults were intramuscularly vaccinated with one dose of the yellow fever vaccine (Stamaril, Sanofi) or the tick-borne encephalitis vaccine (Encepur, GlaxoSmithKline). Peripheral venous blood was collected at the day prior to vaccination and at day 2 after vaccination. Prevaccination controls and postvaccination samples from the same individuals were compared.
Cassetta L., Bruderek K., Skrzeczynska-Moncznik J., Osiecka O., Hu X., Rundgren I.M., Lin A., Santegoets K., Horzum U., Godinho-Santos A., Zelinskyy G., Garcia-Tellez T., Bjelica S., Taciak B., Kittang A.O., Höing B., Lang S., Dixon M., Müller V., Utikal J.S., Karakoç D., Yilmaz K.B., Górka E., Bodnar L., Anastasiou O.E., Bourgeois C., Badura R., Kapinska-Mrowiecka M., Gotic M., ter Laan M., Kers-Rebel E., Król M., Santibañez J.F., Müller-Trutwin M., Dittmer U., de Sousa A.E., Esendağlı G., Adema G., Loré K., Ersvær E., Umansky V., Pollard J.W., Cichy J, & Brandau S. (2020). Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation. Journal for Immunotherapy of Cancer, 8(2), e001223.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!